Avoid common mistakes on your manuscript.
Correction: PharmacoEconomics – Open https://doi.org/10.1007/s41669-024-00490-x
In the following sentences of the first paragraph of Sect. 3, “pembrolizumab plus ipilimumab” should have been “pembrolizumab plus lenvatinib” (two instances):
“The consequences became apparent in a subsequent multiple technology appraisal (MTA; TA858, 2023), whereby neither nivolumab plus ipilimumab nor the new treatment pembrolizumab plus ipilimumab were found to be cost effective versus cabozantinib. NICE compromised, providing a positive recommendation for pembrolizumab plus ipilimumab if, and only if, nivolumab plus ipilimumab would otherwise be offered.”
The article has now been corrected so the sentences read:
“The consequences became apparent in a subsequent multiple technology appraisal (MTA; TA858, 2023), whereby neither nivolumab plus ipilimumab nor the new treatment pembrolizumab plus lenvatinib were found to be cost effective versus cabozantinib. NICE compromised, providing a positive recommendation for pembrolizumab plus lenvatinib if, and only if, nivolumab plus ipilimumab would otherwise be offered.”
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Lee, D., Burns, D. & Wilson, E. Correction: NICE’s Pathways Pilot: Pursuing Good Decision Making in Difficult Circumstances. PharmacoEconomics Open (2024). https://doi.org/10.1007/s41669-024-00499-2
Published:
DOI: https://doi.org/10.1007/s41669-024-00499-2